DrugCite
Search

CAMPATH

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Campath Adverse Events Reported to the FDA Over Time

How are Campath adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Campath, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Campath is flagged as the suspect drug causing the adverse event.

Most Common Campath Adverse Events Reported to the FDA

What are the most common Campath adverse events reported to the FDA?

Pyrexia
375 (2.47%)
Cytomegalovirus Infection
230 (1.52%)
Pneumonia
186 (1.23%)
Pancytopenia
165 (1.09%)
Febrile Neutropenia
161 (1.06%)
Dyspnoea
146 (.96%)
Death
144 (.95%)
Hypotension
140 (.92%)
Neutropenia
140 (.92%)
Respiratory Failure
120 (.79%)
Vomiting
119 (.78%)
Show More Show More
Multi-organ Failure
117 (.77%)
Diarrhoea
113 (.74%)
Renal Failure
111 (.73%)
Nausea
110 (.73%)
Sepsis
110 (.73%)
Platelet Count Decreased
107 (.71%)
Infection
106 (.7%)
Thrombocytopenia
105 (.69%)
Chills
104 (.69%)
Graft Versus Host Disease
98 (.65%)
Anaemia
95 (.63%)
Asthenia
95 (.63%)
Pleural Effusion
95 (.63%)
Leukopenia
87 (.57%)
Fatigue
84 (.55%)
Lymphopenia
78 (.51%)
Renal Failure Acute
78 (.51%)
Abdominal Pain
77 (.51%)
General Physical Health Deteriorati...
74 (.49%)
Haemoglobin Decreased
74 (.49%)
White Blood Cell Count Decreased
72 (.47%)
Epstein-barr Virus Associated Lymph...
69 (.45%)
Septic Shock
69 (.45%)
Chronic Graft Versus Host Disease
67 (.44%)
Headache
67 (.44%)
Transplant Rejection
66 (.44%)
Epstein-barr Virus Infection
65 (.43%)
Acute Respiratory Distress Syndrome
62 (.41%)
Anaemia Haemolytic Autoimmune
60 (.4%)
Dizziness
60 (.4%)
Hepatic Failure
56 (.37%)
Adenovirus Infection
55 (.36%)
Hyperthyroidism
55 (.36%)
Pulmonary Embolism
53 (.35%)
Tachycardia
53 (.35%)
Acute Graft Versus Host Disease In ...
52 (.34%)
Lymphadenopathy
52 (.34%)
Hypertension
51 (.34%)
Blood Creatinine Increased
50 (.33%)
Cough
50 (.33%)
Liver Function Test Abnormal
50 (.33%)
Mental Status Changes
50 (.33%)
Acute Graft Versus Host Disease
48 (.32%)
Decreased Appetite
47 (.31%)
Herpes Zoster
47 (.31%)
Hypoxia
47 (.31%)
Urticaria
46 (.3%)
Atrial Fibrillation
45 (.3%)
Idiopathic Thrombocytopenic Purpura
45 (.3%)
Transplant Failure
45 (.3%)
Confusional State
44 (.29%)
Dehydration
44 (.29%)
Hyponatraemia
44 (.29%)
Ascites
43 (.28%)
Aspartate Aminotransferase Increase...
43 (.28%)
Convulsion
43 (.28%)
Loss Of Consciousness
43 (.28%)
Neutrophil Count Decreased
43 (.28%)
Bronchopulmonary Aspergillosis
42 (.28%)
Urinary Tract Infection
42 (.28%)
Cardiac Failure Congestive
41 (.27%)
Kidney Transplant Rejection
41 (.27%)
Disease Progression
40 (.26%)
Syncope
40 (.26%)
Cardiac Failure
39 (.26%)
Deep Vein Thrombosis
39 (.26%)
Lymphoproliferative Disorder
39 (.26%)
Malignant Neoplasm Progression
39 (.26%)
Pneumonitis
39 (.26%)
Rash
39 (.26%)
Chronic Lymphocytic Leukaemia
38 (.25%)
Hypothyroidism
38 (.25%)
Weight Decreased
37 (.24%)
Alanine Aminotransferase Increased
36 (.24%)
Cytomegalovirus Test Positive
36 (.24%)
Splenomegaly
36 (.24%)
Disease Recurrence
35 (.23%)
Renal Impairment
34 (.22%)
Tumour Lysis Syndrome
34 (.22%)
Chest Pain
33 (.22%)
Hyperglycaemia
31 (.2%)
Pericardial Effusion
31 (.2%)
Bk Virus Infection
30 (.2%)
Blood Pressure Decreased
30 (.2%)
Infusion Related Reaction
30 (.2%)
Blood Glucose Increased
29 (.19%)
Tremor
29 (.19%)
Bone Marrow Failure
28 (.18%)
Fungal Infection
28 (.18%)
Hepatic Function Abnormal
28 (.18%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Campath, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Campath is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Campath

What are the most common Campath adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Campath, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Campath is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Campath According to Those Reporting Adverse Events

Why are people taking Campath, according to those reporting adverse events to the FDA?

Chronic Lymphocytic Leukaemia
841
Multiple Sclerosis
283
Stem Cell Transplant
226
Bone Marrow Conditioning Regimen
176
Peripheral T-cell Lymphoma Unspecif...
93
Renal Transplant
87
Show More Show More
Drug Use For Unknown Indication
73
Acute Lymphocytic Leukaemia
56
T-cell Lymphoma
52
Product Used For Unknown Indication
43
T-cell Prolymphocytic Leukaemia
42
Immunosuppression
41
Acute Leukaemia
33
T-cell Depletion
33
Chronic Lymphocytic Leukaemia Recur...
31
Acute Graft Versus Host Disease
30
Haematological Malignancy
27
Allogenic Bone Marrow Transplantati...
26
Liver Transplant
26
Prophylaxis Against Transplant Reje...
26
Mycosis Fungoides
26
Combined Immunodeficiency
25
Graft Versus Host Disease
24
Immunosuppressant Drug Therapy
24
Acute Myeloid Leukaemia
22
B-cell Small Lymphocytic Lymphoma
22
Prophylaxis Against Graft Versus Ho...
21
Relapsing-remitting Multiple Sclero...
21
Prolymphocytic Leukaemia
13
Chronic Lymphocytic Leukaemia Refra...
12
Non-hodgkins Lymphoma
12
Progressive Multiple Sclerosis
12
Myelodysplastic Syndrome
12
Bone Marrow Transplant
12
Chronic Lymphocytic Leukaemia Stage...
10
Aplastic Anaemia
10
Lymphohistiocytosis
9
Waldenstroms Macroglobulinaemia
9
Bone Marrow Failure
8
Renal And Pancreas Transplant
8
T-cell Chronic Lymphocytic Leukaemi...
8
Lymphoma
8
Pancreas Transplant
7
Kidney Transplant Rejection
7
Transplant Rejection
7
Chronic Myeloid Leukaemia
7
Peripheral T-cell Lymphoma Unspecif...
7
Transplant
6
Organ Transplant
6
Surgical Preconditioning
6
B-cell Lymphoma
6

Drug Labels

LabelLabelerEffective
CampathGenzyme Corporation18-DEC-12

Campath Case Reports

What Campath safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Campath. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Campath.